Ketamine for Endometriosis and Chronic Pelvic Pain: What We Know

Endometriosis affects an estimated 1 in 10 women of reproductive age — approximately 176 million women worldwide. It causes pelvic pain that can be severe, debilitating, and profoundly disruptive to daily life, relationships, and work. It also takes, on average, 7-10 years to diagnose.

For a condition this common and this painful, the treatment options are remarkably limited: hormonal therapy that suppresses the menstrual cycle, surgery to remove lesions, and pain management that too often means lifelong NSAIDs, opioids, or simply being told to manage.

Ketamine is emerging as a meaningful option for a specific component of endometriosis pain — and understanding which component illuminates both why it works for some patients and why it doesn't replace other treatments.

Two Types of Pain in Endometriosis

To understand ketamine's role, it's important to distinguish between two pain mechanisms in endometriosis:

Peripheral sensitization: Pain driven by active endometriotic lesions — inflammation, nerve infiltration, and prostaglandin release at the tissue level. This is site-specific and directly related to the lesions themselves.

Central sensitization: Over time, repeated peripheral pain signals rewire the central nervous system. The spinal cord and brain become hypersensitized — amplifying signals that should be moderate, producing pain in response to stimuli that shouldn't cause pain (allodynia), and generating pain even when active disease is absent or surgically removed.

This is why many endometriosis patients continue to have significant pain even after successful surgery. The peripheral lesions may be gone, but the central nervous system has been remodeled by years of pain input, and it keeps generating the pain signal on its own.

Ketamine primarily addresses central sensitization. It does not remove endometriotic lesions or reduce peripheral inflammation. But it can significantly interrupt the central amplification process — which is exactly the component that makes endometriosis pain so treatment-resistant.

The Evidence Base

The research on ketamine specifically for endometriosis is emerging, not yet definitive. There are small case series and some clinical trial data, and ketamine's effectiveness in central sensitization syndromes more broadly (fibromyalgia, CRPS, chronic pelvic pain of other etiologies) is better established.

What we know from related research:

• Ketamine has demonstrated meaningful efficacy in central sensitization syndromes, with response rates of 40-70% in studies on fibromyalgia and CRPS — conditions that share the central sensitization mechanism with chronic pelvic pain.
• Patients with endometriosis who also meet criteria for central sensitization (widespread pain, hyperalgesia, chronic fatigue, sleep disturbance) appear to be the best candidates for ketamine.
• Ongoing clinical trials are specifically investigating ketamine for chronic pelvic pain with central sensitization.

The Depression and Anxiety Component

One thing that's consistently underappreciated: endometriosis doesn't just cause physical pain. It causes profound psychological suffering.

Years of undiagnosed pain dismissed by physicians. The impact on fertility. Disrupted relationships and careers. The grief associated with a chronic condition affecting the most intimate aspects of life. Rates of depression and anxiety in endometriosis patients are significantly elevated — and are often undertreated.

Ketamine addresses both the pain and the psychological components simultaneously. The same neuroplasticity mechanism that produces antidepressant effects also modulates central sensitization. For patients dealing with both the physical and psychological burden of endometriosis, this dual action is clinically significant.

See related discussions in our posts on ketamine for fibromyalgia and chronic pain and understanding treatment-resistant depression.

Who Is Most Likely to Respond?

Based on current clinical evidence, ketamine for endometriosis pain is most appropriate for patients who:

• Have a confirmed endometriosis diagnosis
• Have central sensitization features (widespread pain, allodynia, hypersensitivity to stimuli beyond the pelvis, chronic fatigue)
• Have not achieved adequate pain control with hormonal therapy, surgery, or standard analgesics
• Have comorbid depression or anxiety that is also inadequately treated
• Are not pregnant and do not have ketamine contraindications

Patients whose pain is primarily peripheral (active lesions, clearly cyclic pain that resolves with hormonal suppression) are less likely to benefit from ketamine alone.

What Ketamine Treatment Looks Like for Pelvic Pain

For chronic pelvic pain and endometriosis, treatment typically begins with an initial series of 4-6 sublingual ketamine sessions over 2-3 weeks. The goal of the initial series is to reduce the baseline level of central sensitization — think of it as recalibrating the nervous system's amplification dial.

After the initial series, maintenance sessions are scheduled based on response. Some patients find monthly sessions keep them at a significantly improved functional baseline; others can extend to every 6-8 weeks.

The at-home format with Discreet Ketamine has particular value for pelvic pain patients, many of whom have conditions that make travel and clinic visits painful and exhausting. Being able to treat in your own space, lying comfortably, without commuting or waiting, changes the experience significantly.

What Ketamine Won't Do

Ketamine is not a cure for endometriosis. It does not remove lesions, reduce estrogen-driven disease progression, or address the hormonal component of the condition. It should be considered an adjunct to — not a replacement for — appropriate gynecological care.

For patients with active endometriosis, ketamine treatment is best approached in coordination with your gynecologist or endometriosis specialist. Your Discreet Ketamine physician will want to understand your full treatment picture.

Realistic Expectations

The research suggests that patients with endometriosis and significant central sensitization can achieve meaningful pain reduction — often 30-60% improvement in pain scores — with ketamine treatment. This doesn't mean pain-free; it means a pain level that allows for significantly better quality of life, function, and participation in treatment of the underlying disease.

For many endometriosis patients who have been told "there's nothing else we can do," that level of improvement can be transformative.

If you're living with endometriosis or chronic pelvic pain and standard treatments haven't provided adequate relief, we'd encourage you to explore whether ketamine is a fit. Take our eligibility quiz to start a conversation with our physician team, or read more about our approach to chronic pain in our treatment library.